Reuters logo
BRIEF-Galapagos reports goals for efficacy of GLPG1205 in patients with UC were not met
January 26, 2016 / 7:02 AM / 2 years ago

BRIEF-Galapagos reports goals for efficacy of GLPG1205 in patients with UC were not met

Jan 26 (Reuters) - Galapagos NV :

* Reports results with GLPG1205 in ulcerative colitis

* Phase 2a study confirms good pharmacokinetics, safety and tolerability

* Endpoints for efficacy of GLPG1205 in patients with ulcerative colitis (UC), however, were not met.

* Will discontinue clinical development in UC

* Origin study results showed that GLPG1205 did not statistically significantly differentiate from placebo on (partial) Mayo scores Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below